trending Market Intelligence /marketintelligence/en/news-insights/trending/Ghm6liG0NW_iTmHtmMow1Q2 content esgSubNav
In This List

Generex adds Emmaus CEO to board

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


Generex adds Emmaus CEO to board

Generex Biotechnology Corp. added Emmaus Life Sciences Inc. Chairman and CEO Yutaka Niihara to its board of directors as executive chairman.

Generex Biotechnology previously signed a letter of intent to acquire a 51% interest in Emmaus.